LIGAND PHARMACEUTICALS INC·4

Dec 27, 6:31 PM ET

Gray Nancy Ryan 4

4 · LIGAND PHARMACEUTICALS INC · Filed Dec 27, 2022

Insider Transaction Report

Form 4
Period: 2022-12-22
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2022-12-22+3,0503,050 total
    Exercise: $67.03Exp: 2032-12-22Common Stock (3,050 underlying)
Footnotes (1)
  • [F1]Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023.

Documents

2 files